{
    "info": {
        "nct_id": "NCT03164616",
        "official_title": "A Phase III, Randomized, Multi-Center, Open-Label, Comparative Global Study to Determine the Efficacy of Durvalumab or Durvalumab and Tremelimumab in Combination With Platinum-Based Chemotherapy for First-Line Treatment in Patients With Metastatic Non Small-Cell Lung Cancer (NSCLC) (POSEIDON)",
        "inclusion_criteria": "For inclusion in the study, patients should fulfill the following criteria:\n\n1. Aged at least 18 years.\n2. Histologically or cytologically documented Stage IV NSCLC.\n3. Confirmed tumor PD-L1 status prior to randomization.\n4. Patients must have tumors that lack activating EGFR mutations and ALK fusions.\n5. No prior chemotherapy or any other systemic therapy for metastatic NSCLC.\n6. World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\n7. No prior exposure to immunemediated therapy, excluding therapeutic anticancer vaccines.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 130 Years",
        "exclusion_criteria": "Patients should not enter the study if any of the following exclusion criteria are fulfilled:\n\n1. Mixed small-cell lung cancer and NSCLC histology, sarcomatoid variant.\n2. Active or prior documented autoimmune or inflammatory disorders.\n3. Brain metastases or spinal cord compression unless the patient's condition is stable and off steroids.\n4. Active infection including tuberculosis, hepatitis B, hepatitis C, or human immunodeficiency virus.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "3. Confirmed tumor PD-L1 status prior to randomization.",
            "criterions": [
                {
                    "exact_snippets": "Confirmed tumor PD-L1 status prior to randomization.",
                    "criterion": "tumor PD-L1 status",
                    "requirements": [
                        {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to randomization"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Histologically or cytologically documented Stage IV NSCLC.",
            "criterions": [
                {
                    "exact_snippets": "Histologically or cytologically documented",
                    "criterion": "NSCLC diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Stage IV NSCLC",
                    "criterion": "NSCLC stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "IV"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Patients must have tumors that lack activating EGFR mutations and ALK fusions.",
            "criterions": [
                {
                    "exact_snippets": "tumors that lack activating EGFR mutations",
                    "criterion": "tumor EGFR mutation status",
                    "requirements": [
                        {
                            "requirement_type": "activating EGFR mutation presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "tumors that lack ... ALK fusions",
                    "criterion": "tumor ALK fusion status",
                    "requirements": [
                        {
                            "requirement_type": "ALK fusion presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. No prior chemotherapy or any other systemic therapy for metastatic NSCLC.",
            "criterions": [
                {
                    "exact_snippets": "No prior chemotherapy ... for metastatic NSCLC",
                    "criterion": "prior chemotherapy for metastatic NSCLC",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "No prior ... any other systemic therapy for metastatic NSCLC",
                    "criterion": "prior systemic therapy for metastatic NSCLC",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. No prior exposure to immunemediated therapy, excluding therapeutic anticancer vaccines.",
            "criterions": [
                {
                    "exact_snippets": "No prior exposure to immunemediated therapy",
                    "criterion": "prior exposure to immune-mediated therapy",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "excluding therapeutic anticancer vaccines",
                    "criterion": "prior exposure to therapeutic anticancer vaccines",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": "allowed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 130 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 130 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 130,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.",
            "criterions": [
                {
                    "exact_snippets": "World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
                    "criterion": "WHO/ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Aged at least 18 years.",
            "criterions": [
                {
                    "exact_snippets": "Aged at least 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "Patients should not enter the study if any of the following exclusion criteria are fulfilled:",
            "criterions": [
                {
                    "exact_snippets": "Patients should not enter the study if any of the following exclusion criteria are fulfilled:",
                    "criterion": "fulfillment of exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Mixed small-cell lung cancer and NSCLC histology, sarcomatoid variant.",
            "criterions": [
                {
                    "exact_snippets": "Mixed small-cell lung cancer and NSCLC histology",
                    "criterion": "lung cancer histology",
                    "requirements": [
                        {
                            "requirement_type": "histological type",
                            "expected_value": [
                                "mixed small-cell lung cancer",
                                "NSCLC"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "sarcomatoid variant",
                    "criterion": "sarcomatoid variant",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Active or prior documented autoimmune or inflammatory disorders.",
            "criterions": [
                {
                    "exact_snippets": "Active or prior documented autoimmune or inflammatory disorders",
                    "criterion": "autoimmune or inflammatory disorders",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "active",
                                "prior documented"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Brain metastases or spinal cord compression unless the patient's condition is stable and off steroids.",
            "criterions": [
                {
                    "exact_snippets": "Brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "spinal cord compression",
                    "criterion": "spinal cord compression",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "unless the patient's condition is stable",
                    "criterion": "condition stability (brain metastases or spinal cord compression)",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "off steroids",
                    "criterion": "steroid use (for brain metastases or spinal cord compression)",
                    "requirements": [
                        {
                            "requirement_type": "current steroid use",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Active infection including tuberculosis, hepatitis B, hepatitis C, or human immunodeficiency virus.",
            "criterions": [
                {
                    "exact_snippets": "Active infection including tuberculosis, hepatitis B, hepatitis C, or human immunodeficiency virus",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "tuberculosis",
                    "criterion": "tuberculosis infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis B",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis C",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "human immunodeficiency virus",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "For inclusion in the study, patients should fulfill the following criteria:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}